Peer-reviewedCC BY-NC-ND 4.0Proceedings of the National Academy of Sciences of the United States of America
Harnessing autoantibodies to target pathogenic plasma cells
- 1Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, The Australian National University, Canberra 2600, ACT, Australia
Related
- Bone marrow kinase X-linked in pulmonary diseases: pathogenic gene, diagnostic biomarker, and treatment target—a narrative review
- Molecular Diagnostics of Pathogenic Vibrio: Target Selection, Detection Platforms, and Challenges in Field Applications.
- Integrating Control-Mastery Theory and EMDR in the treatment of attachment-related trauma: pathogenic beliefs, testing processes, and target selection
- Cold atmospheric plasma accelerates wound closure and reduces pathogenic bacterial load in diabetic foot ulcers: a randomized controlled trial
- Sympathovagal Imbalance and Insulin Resistance: The Autonomic Nervous System as a Convergent Therapeutic Target for Breaking a Bidirectional Pathogenic Cycle
BibTeX
@article{ellyard2026harnessing,
title = {{Harnessing autoantibodies to target pathogenic plasma cells}},
author = {Julia I. Ellyard and Anselm Enders},
journal = {Proceedings of the National Academy of Sciences of the United States of America},
year = {2026},
month = oct,
doi = {10.1073/pnas.2631232123},
url = {https://doi.org/10.1073/pnas.2631232123},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Harnessing autoantibodies to target pathogenic plasma cells
AU - Julia I. Ellyard
AU - Anselm Enders
PY - 2026
DA - 2026/10/20
JO - Proceedings of the National Academy of Sciences of the United States of America
DO - 10.1073/pnas.2631232123
UR - https://doi.org/10.1073/pnas.2631232123
SN - 0027-8424
SN - 1091-6490
ER -